 |  |  |  |  |  |
| © 2008 Catalyst Financial Resources, LLC. The information contained here should not be the only basis for investment decisions. |
| Client Profile |
CTT
www.competitivetech.net
Competitive Technologies, Inc. pursues the Chemotherapy Induced Peripheral Neuropathy
(CIPN) market. Their Calmare Therapy Treatment can be a critical part of palliative care for pain
management for critically ill patients.
www.competitivetech.net
Competitive Technologies, Inc. pursues the Chemotherapy Induced Peripheral Neuropathy
(CIPN) market. Their Calmare Therapy Treatment can be a critical part of palliative care for pain
management for critically ill patients.
Equity Research Investor
Presentation
Email Alerts
Comments